Company Description
Thermogenesis Holdings (OTC Link: THMO) is a publicly traded medical devices company in the Laboratory Apparatus & Furniture sector. The company has a market capitalization of $5.4M, ranking #6,669 among all listed U.S. companies by market cap.
On a trailing twelve-month basis, Thermogenesis Holdings reported revenue of $9.4M with net income of -$18.9M. The company operates at a net profit margin of -200.3%.
This page provides a comprehensive overview of THMO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Thermogenesis Holdings (THMO) stock last traded at $0.0001. At a market capitalization of $5.4M, THMO is classified as a micro-cap stock with approximately 15.8M shares outstanding.
Latest News
Thermogenesis Holdings has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, management. View all THMO news →
SEC Filings
Financial Highlights
Thermogenesis Holdings generated $9.4M in revenue over the trailing twelve months, retaining a 20.4% gross margin, operating income reached -$8.6M (-91.2% operating margin), and net income was -$18.9M, reflecting a -200.3% net profit margin. The company generated -$3.7M in operating cash flow. With a current ratio of 0.44, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Thermogenesis Holdings (THMO) currently stands at 345 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 69.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Thermogenesis Holdings (THMO) currently stands at 69.0 days, up 880.1% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 80.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 346.0 days.
THMO Company Profile & Sector Positioning
Thermogenesis Holdings (THMO) operates in the Medical Devices industry within the broader Laboratory Apparatus & Furniture sector and is listed on the OTC Link.
Investors comparing THMO often look at related companies in the same sector, including Opgen (OPGN), Motus Gi Hldgs Inc (MOTS), Pressure Bio (PBIO), Micron Solutions (MICR), and Nemaura Med Inc (NMRD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate THMO's relative position within its industry.